BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2949601)

  • 1. Effects of vasopressin on portal hemodynamics in patients with portal hypertension.
    Ohnishi K; Saito M; Nakayama T; Hatano H; Okuda K
    Am J Gastroenterol; 1987 Feb; 82(2):135-8. PubMed ID: 2949601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propranolol on portal hemodynamics in patients with chronic liver disease.
    Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H
    Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
    Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
    Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vasopressin on regional splanchnic blood flows in conscious man.
    Erwald R; Wiechel KL; Strandell T
    Acta Chir Scand; 1976; 142(1):36-42. PubMed ID: 1266541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
    Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
    Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
    Ganger DR; Gottstein J; Blei AT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
    Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.
    Nygren A; Thorén A; Ricksten SE
    Acta Anaesthesiol Scand; 2009 May; 53(5):581-8. PubMed ID: 19239407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
    Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
    Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
    Millette B; Huet PM; Lavoie P; Viallet A
    Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
    Barr JW; Lakin RC; Rösch J
    Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
    Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
    J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations.
    Dubois A; Dauzat M; Pignodel C; Pomier-Layrargues G; Marty-Double C; Lopez FM; Janbon C
    Hepatology; 1993 Feb; 17(2):246-50. PubMed ID: 8428721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.